LCD-L40056
Document details
Summary
The new guidelines for Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) will significantly impact billing practices, particularly in how services are documented and coded for reimbuNew AIT guidelines affect billing practices.
Affected codes
ICD-10-CM
Affected specialty
Allergy/Immunology alerts →Source document
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=40056&ver=3CLV Intelligence summarizes publicly available federal publications. Not affiliated with or endorsed by any government agency.
Related alerts
4Policy LCD-DL40050 · Allergy/Immunology
The proposed Local Coverage Determination (LCD) on Allergen Immunotherapy may impact billing practices for providers offering subcutaneous immunotherapy. It could lead to higher reimbursement rates fo
View alertPolicy LCD-DL40052 · Allergy/Immunology
The proposed LCD for Allergen Immunotherapy may significantly influence billing practices related to Subcutaneous Immunotherapy. Providers will need to ensure proper documentation and coding align wit
View alertPolicy LCD-DL40048 · Allergy/Immunology
The proposed LCD for Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) could have significant billing implications, particularly for allergists and practices specializing in immunoth
View alertPolicy LCD-DL39314 · Allergy/Immunology
The proposed LCD addresses the billing implications for off-label uses of IVIG, which may affect reimbursement rates and eligibility for coverage under Medicare. Providers need to stay informed about
View alert